Vaccines

Topic

Resource Type

Resource Type

Turn the pages to explore the toolkit or download the toolkit. You may also watch the webinar recording that introduces the toolkit. Components of the Vaccine Communication Toolkit are also available in Spanish, Haitian Creole, and Vietnamese. Please scroll below the English components on this page to find materials in these three languages. 

Frequently Asked Questions

SCCAHS COVID-19 Vaccine Town Hall 
Dr. Glenn Morris, Center director and director of the University of Florida Emerging Pathogens Institute, and Dr. Ira Longini, Co-director of Center for Statistics and Quantitative Infectious Diseases provided the...
View Resource
Delta Variant Instagram Story Graphics
View Resource
Delta Varient X/Twitter Graphics
View Resource
Delta Variant Facebook Graphics
View Resource
Delta Varient Information Sheet
View Resource
Materials in Vietnamese
View Resource
Materials in Hatian Creole
View Resource
Materials in Spanish
View Resource
Instagram Graphics
View Resource
X/Twitter Graphics
View Resource
Vaccine Toolkit
View Resource
Facebook Graphics
View Resource
Guest News Column
[State residents] are anxious to move past COVID-19 and return to normal in the workplace and the marketplace.
View Resource
Vaccine Information Sheets
View Resource

Frequently Asked Questions

Common Questions about the Vaccine

Yes! The vaccines generate a strong immune response against a key protein the virus needs to establish an infection. It is beneficial to have the immune system make these neutralizing antibodies to best protect against another infection.

At this time, there appears to be no real difference between the Pfizer and Moderna vaccines in safety or effectiveness.

Neither the Pfizer nor the Moderna vaccine contains the coronavirus, so recipients cannot be infected with COVID-19 through its administration.

Side effects that have been reported are similar to those identified after other vaccines including: arm soreness, muscle and joint aches, headache, fatigue, chills and low-grade fever. These mild to moderate reactions appear to be relatively common especially after the second dose.
COVID-19 vaccine studies evaluated development of COVID-19 illness with symptoms. It is not known at this time whether you can spread COVID-19 to others if you become infected after vaccination.
You should isolate and get tested for COVID-19 as the vaccine is not 100% effective and it is unclear how long people will maintain immunity after vaccination.

Individuals who are Pregnant or Nursing

The Pfizer and Moderna vaccines are considered low-risk for people who are pregnant. The American College of Obstetricians and Gynecologists (ACOG) recommends that COVID-19 vaccines should NOT be withheld from pregnant women who meet criteria for vaccination based on priority groups.
A conversation with your clinician may be helpful, but no clearance or letter is required.
COVID-19 vaccination is recommended to be offered to women considering or actively pursuing pregnancy. Pregnancy testing is not recommended prior to vaccination. If pregnancy is identified after the first dose, the second dose should be taken.
Level of exposure risk and community prevalence are important considerations. Pregnant women are vulnerable to more severe illness from COVID-19 compared to nonpregnant women of reproductive age.

Individuals who are Immunocompromised

The Pfizer and Moderna vaccines are considered low-risk for people who are pregnant. The American College of Obstetricians and Gynecologists (ACOG) recommends that COVID-19 vaccines should NOT be withheld from pregnant women who meet criteria for vaccination based on priority groups.
A conversation with your clinician may be helpful, but no clearance or letter is required.
COVID-19 vaccination is recommended to be offered to women considering or actively pursuing pregnancy. Pregnancy testing is not recommended prior to vaccination. If pregnancy is identified after the first dose, the second dose should be taken.
Level of exposure risk and community prevalence are important considerations. Pregnant women are vulnerable to more severe illness from COVID-19 compared to nonpregnant women of reproductive age.